Search

Search results

Complementary data: Dates Languages and formats available Classifications
Display results:
    Page 1    of    95 -     >     >>
  • E2011J0014

    Judgment of the Court of 21 December 2012 in Case E-14/11 — Schenker North AB, Schenker Privpak AB and Schenker Privpak AS v EFTA Surveillance Authority (Action for annulment of a decision of the EFTA Surveillance Authority — Access to documents — Admissibility — Measures of Organization of Procedure — Reopening of oral procedure)

     OJ C 118, 25.4.2013, p. 35–35 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • E2013C0327(01)

    View of the representatives of the EFTA States and the EFTA Surveillance Authority presented at the meeting of the EC Advisory Committee on restrictive agreements and dominant position of 28 November 2012 regarding a preliminary draft Commission Decision Case COMP/39.230 — Rio Tinto Alcan — Rapporteur: The Netherlands

     OJ C 89, 27.3.2013, p. 7–7 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 52013XC0327(01)

    Summary of Commission Decision of 20 December 2012 relating to a proceeding under Articles 101 and 102 of the Treaty on the Functioning of The European Union and Articles 53 and 54 of the EEA Agreement (Case COMP/39.230 — Rio Tinto Alcan) (notified under document C(2012) 9439) Text with EEA relevance

     OJ C 89, 27.3.2013, p. 5–6 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 52013XX0327(02)

    Final Report of the Hearing Officer — COMP/39.230 — Réel/Alcan

     OJ C 89, 27.3.2013, p. 4–4 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 52013XX0327(01)

    Opinion of the Advisory Committee on restrictive agreements and dominant position given at its meeting of 28 November 2012 regarding a draft decision relating to Case COMP/39.230 — Rio Tinto Alcan — Rapporteur: The Netherlands

     OJ C 89, 27.3.2013, p. 3–3 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 52013XX0313(01)

    Opinion of the Advisory Committee on restrictive agreements and dominant position given at its meeting of 27 November 2012 regarding a draft decision relating to Case COMP/39.847 — E-BOOKS — Rapporteur: Lithuania

     OJ C 73, 13.3.2013, p. 14–14 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 62012CN0554

    Case C-554/12 P: Appeal brought on 30 November 2012 by the European Commission against the judgment delivered by the General Court (Sixth Chamber) on 20 September 2012 in Case T-421/09 DEI v European Commission

     OJ C 32, 2.2.2013, p. 11–11 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 62012CN0553

    Case C-553/12 P: Appeal brought on 30 November 2012 by the European Commission against the judgment delivered by the General Court (Sixth Chamber) on 20 September 2012 in Case T-169/08 DEI v Commission

     OJ C 32, 2.2.2013, p. 10–11 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 62012CN0497

    Case C-497/12: Reference for a preliminary ruling from the Tribunale Amministrativo Regionale per la Sicilia (Italy), lodged on 7 November 2012 — Davide Gullotta, Farmacia di Gullotta Davide & C. Sas v Ministero della Salute, Azienda Sanitaria Provinciale di Catania

     OJ C 26, 26.1.2013, p. 25–26 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


  • 62010CA0457

    Case C-457/10 P: Judgment of the Court (First Chamber) of 6 December 2012 — AstraZeneca AB, AstraZeneca plc v European Commission, European Federation of Pharmaceutical Industries and Associations (EFPIA) (Appeals — Competition — Abuse of dominant position — Market in anti-ulcer medicines — Abuse of procedures relating to supplementary protection certificates for medicinal products and of marketing authorisation procedures for medicinal products — Misleading representations — Deregistration of marketing authorisations — Obstacles to the marketing of generic medicinal products and to parallel imports)

     OJ C 26, 26.1.2013, p. 2–2 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)


    Page 1    of    95 -     >     >>
Top



Managed by the Publications Office